You are here: Industry Insights > trial

News List

MedDay Announces Full Patient Enrollment for MD1003 Trial November 10, 2018
MedDay Pharmaceuticals announced full enrollment of SPI2, a phase III clinical trial designed to confirm the potential of its investigational drug MD1003 in progressive MS as shown in MS-SPI phase III trial.
MedDay Announces Full Patient Enrollment for MD1003 Trial November 10, 2018
MedDay Pharmaceuticals announced full enrollment of SPI2, a phase III clinical trial designed to confirm the potential of its investigational drug MD1003 in progressive MS as shown in MS-SPI phase III trial.
Protagonist Therapeutics Announces Completion of Phase 1 Trial of PTG-200 americanpharmaceuticalreview
November 07, 2018
Protagonist Therapeutics Announces Completion of Phase 1 Trial of PTG-200
The biggest ever trial for secondary progressive multiple sclerosis (SPMS) has kicked off in the UK at around 30 sites in England, Scotland, Wales, Northern Ireland and Eire. pharmatimes
September 18, 2018
The biggest ever trial for secondary progressive multiple sclerosis (SPMS) has kicked off in the UK at around 30 sites in England, Scotland, Wales, Northern Ireland and Eire.
Researchers conduct ASPREE trial to study the effect of Aspirin on old people biospectrumasia
September 18, 2018
The ASPREE trial of more than 19,000 participants in Australia and the US is the largest and most comprehensive study to look at whether the many millions of older people around the world who take (100mg) low dose aspirin to preserve good health are deriv
First Patient Dosed in DSP-0509 Trial americanpharmaceuticalreview
September 14, 2018
Boston Biomedical has initiated clinical trial activities for DSP-0509, an investigational Toll-like receptor (TLR) 7 agonist. DSP-0509 is hypothesized to induce cytokine production, activate cytotoxic T lymphocytes, and sustain the immune-mediated antitu
Anifrolumab Trial Does Not Meet Primary Endpoint americanpharmaceuticalreview
September 03, 2018
AstraZeneca and MedImmune announced top-line results from the TULIP 1 Phase III trial for anifrolumab in adult patients with moderate-to-severe systemic lupus erythematosus (SLE).
Impel Neuropharma Announces First Patient Dosed In INP104 Trial americanpharmaceuticalreview
August 27, 2018
Impel NeuroPharma announced the first patient has been dosed in the company's Phase 3, open-label safety and tolerability study evaluating long-term, intermittent use of INP104 for the treatment of migraine headache.
Teva pulls fremanezumab cluster headaches trial pharmatimes
June 21, 2018
Teva is discontinuing a late-stage trial assessing the efficacy of its experimental anti-CGRP therapy fremanezumab in reducing cluster headaches.
Trial suggests KaNDy’s menopause drug could be better than HRT fiercebiotech
June 11, 2018
New women’s health biotech KaNDy Therapeutics—rumored to have attracted buyout interest from Allergan—has just reported data on its lead product that could enhance its allure.

Previous page 1 2 3 4 5 6 7 8 9 10 11 12 13 Next page